Ipergay trial: PrEP still protected people who had less sex and used it less often
Another HIV vaccine efficacy trial will start this year
Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
90-90-90 progress in southern Africa: HIV testing gap needs to be closed in young people and men
Can self-testing engage 'hard-to-reach' men with HIV testing?
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show
New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?
International study of gay couples reports no transmissions from an HIV-positive partner on treatment
New study finds that gay men on HIV treatment don't pass the virus to sexual partners
